This report provides an early analysis of cases of tuberculosis (TB) disease reported to the Centers for Disease Control and Prevention (CDC) during 2024 as compared with previous years. CDC used U.S. Census Bureau population estimates to calculate rates (cases per 100,000 persons) of TB disease.
This report outlines the National Institute of Allergy and Infectious Diseases' (NIAID) updated strategic plan to combat tuberculosis. It focuses on four key priorities: enhancing fundamental knowledge of TB, advancing diagnostic research, accelerating vaccine development, and supporting strategies to treat and prevent TB.
This webpage discusses the critical role of early testing, diagnosis, and treatment in controlling the spread of tuberculosis (TB) and saving lives. It highlights local efforts to improve TB prevention and care, focusing on the impact of timely intervention on reducing TB transmission in specific communities.
This webpage provides an overview of hepatitis B, including its causes, symptoms, diagnosis, and treatment options. It emphasizes the importance of vaccination in preventing the spread of hepatitis B and reducing the risk of liver cancer and other serious health complications.
This infographic provides an overview of hepatitis B, detailing its transmission, symptoms, and prevention strategies.
This fact sheet presents key talking points emphasizing the critical importance of administering the hepatitis B vaccine birth dose to newborns.
This webpage presents data on newly reported chronic hepatitis C cases in Alaska from 2016 to 2023. It underscores the importance of continued hepatitis C surveillance to guide targeted testing and treatment efforts toward disease elimination.
This booklet provides comprehensive information on hepatitis C, detailing its impact on liver health, modes of transmission, symptoms, and the importance of testing and treatment. The booklet outlines the progression from acute to chronic infection, potential liver complications, and available diagnostic tests.
This journal discusses the integration of hepatitis C management into primary care as a key strategy for eliminating the disease. It examines barriers to care, the role of direct-acting antivirals, and the importance of screening and treatment within primary care settings.
Contact organization for eligibility
